Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
UMSC-derived Exosomes for Dry Eye in cGVHD
NCT04213248Phase 2Unknown
- Sponsor
- Zhongshan Ophthalmic Center
- Start
- Feb 2020
- Primary completion
- May 2023
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial in dry eye syndrome (DED), sponsored by Zhongshan Ophthalmic Center. Primary endpoint: Ocular Surface Disease Index at 12 weeks. Status: unknown.
02
Conditions
dry eye syndrome (DED)
Beyond the preview
Go deeper on NCT04213248.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04213248.